| 摘要 |
FIELD: medicine, rheumatology. ^ SUBSTANCE: invention can be used for treatment of patients with ankylosing spondylarthritis. Method involves using prospidin in the dose 300 mg per a week by intravenous route administration as the basic therapy on stationary stage and then in the dose 100-200 mg by intramuscular administration on ambulatory stage. Method provides the early and prolonged clinical effect in treatment. ^ EFFECT: enhanced effectiveness of treatment. ^ 6 tbl, 2 ex |
